Abst 0501 Kakkar & colleagues examined immunogenicity of single dose of SARS-CoV-2 Vaccine in patients with systemic sclerosis - Vaccine is safe - Immunosuppression lowered Ab production but no effect on T cell response #ACR21 @RheumNow https://t.co/NsLrWHh7ZS